Company intelligence / Profile preview

Lung Innovations Network

Multiple (focus: central and western PA), Pennsylvania, United States

Ownership: Private
Development stage: Other

Overview

Lung Innovations Network is a multidisciplinary healthcare and clinical research organization specializing in advanced lung care, diagnostics, and the conduct of clinical trials, serving over 10,000 patients annually in Pennsylvania. The group has integrated the CyPath® Lung diagnostic (92% sensitivity, 87% specificity for early-stage lung cancer) into routine clinical workflow. The group is a Center of Excellence recognized by the Lung Cancer Alliance, UPMC, and the American College of Radiology[1][2][3][9].

Therapeutic areas: OncologyPulmonology
Modalities: DeviceDiagnostic testNon-pharmacological therapy
Industry: Academic Hospital/University/Research

Partnerships

bioAffinity TechnologiesPenn Highlands Healthcare

Beyond the preview

Go deeper on Lung Innovations Network.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lung Innovations Network.

Explore the full profile